We are currently recruiting dogs with multicentric lymphoma for multiple ongoing clinical studies.
Learn more about our Canine B-cell Lymphoma Trial
Learn more about our Canine T-Cell Lymphoma Trial
If you are a veterinarian interested in referring a canine patient with lymphoma for treatment, or if you would like additional information about these studies, please call the Purdue Veterinary Hospital at 765-494-1107 and ask to speak with Ms. Sarah Lahrman, RVT, or Dr. Michael Childress.
Please note that treatment of canine lymphoma with prednisone prior to initiation of multidrug chemotherapy has been associated with increased chemotherapeutic drug resistance and reduced remission and survival times. Therefore, dogs previously treated with prednisone are unfortunately not eligible for some of the ongoing trials.
If you are a veterinarian interested in referring a canine patient with lymphoma to the Purdue University Veterinary Hospital for treatment, please do not prescribe prednisone for that patient.
We realize that lymphomas may progress rapidly and that prompt treatment is imperative for optimal patient care. We therefore make every effort to receive patients with a confirmed or tentative diagnosis of lymphoma as quickly as possible. Usually, appointments are available within 24-48 hours.